Favorable response to doxorubicin combination chemotherapy does not yield good clinical outcome in patients with metastatic breast cancer with triple-negative phenotype.
Yi
Seong Yoon
SY
Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Ahn
Jin Seok
JS
Uhm
Ji Eun
JE
Lim
Do Hyoung
DH
Ji
Sang Hoon
SH
Jun
Hyun Jung
HJ
Kim
Kyoung Ha
KH
Chang
Myung Hee
MH
Park
Min Jae
MJ
Cho
Eun Yoon
EY
Choi
Yoon La
YL
Park
Yeon Hee
YH
Im
Young-Hyuck
YH